{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T20:04:06Z","timestamp":1778789046317,"version":"3.51.4"},"reference-count":163,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100001465","name":"American Thoracic Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001465","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chronic obstructive pulmonary disease (COPD) is a highly prevalent and burdensome disease that develops over decades. Treatments for COPD are most commonly prescribed in later stages of the disease, leaving missed opportunities to modify the course of disease at earlier stages. This workshop was conducted to promote progress in the design and conduct of clinical trials of treatments that modify progression to COPD. The aims of the workshop were to provide an operational definition of pre-COPD and to discuss the elements and design of potential clinical trials in pre-COPD. The key focus areas of this workshop included: (1) defining a study population for pre-COPD clinical trials; (2) endpoints in pre-COPD clinical trials; and (3) design considerations for pre-COPD clinical trials.<\/jats:p>","DOI":"10.1093\/annalsats\/aaoag034","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T17:38:53Z","timestamp":1770831533000},"page":"667-688","source":"Crossref","is-referenced-by-count":1,"title":["Disease modification and progression in pre\u2013chronic obstructive pulmonary disease: an official American Thoracic Society workshop report"],"prefix":"10.1093","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0688-1836","authenticated-orcid":false,"given":"Nirupama","family":"Putcha","sequence":"first","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine , Baltimore, MD,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8418-4497","authenticated-orcid":false,"given":"Surya P","family":"Bhatt","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham , Birmingham, AL,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4336-3835","authenticated-orcid":false,"given":"Jessica","family":"Bon","sequence":"additional","affiliation":[{"name":"Section of Pulmonary, Critical Care, Allergy, and Immunologic Diseases, Wake Forest University , Winston-Salem, NC,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie A","family":"Christenson","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, University of California San Francisco , San Francisco, CA,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MeiLan K","family":"Han","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care, University of Michigan , Ann Arbor, MI,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5525-4778","authenticated-orcid":false,"given":"Jerry A","family":"Krishnan","sequence":"additional","affiliation":[{"name":"Breathe Chicago Center, University of Illinois Chicago , Chicago, IL,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando J","family":"Martinez","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, University of Massachusetts Chan Medical School\/UMassMemorial Hospital , Worcester, MA,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8851-8589","authenticated-orcid":false,"given":"Richard","family":"Casaburi","sequence":"additional","affiliation":[{"name":"Respiratory Research Center, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center , Torrance, CA,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James D","family":"Crapo","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care and Sleep Medicine, National Jewish Health , Denver, CO,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5191-4847","authenticated-orcid":false,"given":"Jeffrey L","family":"Curtis","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care, University of Michigan , Ann Arbor, MI,","place":["United States"]},{"name":"Medical Service, VA Ann Arbor HealthCare System , Ann Arbor, MI,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory B","family":"Diette","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine , Baltimore, MD,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark T","family":"Dransfield","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham , Birmingham, AL,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8587-8343","authenticated-orcid":false,"given":"Michelle N","family":"Eakin","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine , Baltimore, MD,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2443-0876","authenticated-orcid":false,"given":"Ravi","family":"Kalhan","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Northwestern University Feinberg School of Medicine , Chicago, IL,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3646-7828","authenticated-orcid":false,"given":"David M","family":"Mannino","sequence":"additional","affiliation":[{"name":"COPD Foundation , Miami, FL,","place":["United States"]},{"name":"Division of Pulmonary, Critical and Sleep Medicine, University of Kentucky College of Medicine , Lexington, KY,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5274-7574","authenticated-orcid":false,"given":"Maria","family":"Montes de Oca","sequence":"additional","affiliation":[{"name":"School of Medicine, Central University of Venezuela , Caracas,","place":["Venezuela"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugh","family":"Musick","sequence":"additional","affiliation":[{"name":"Breathe Chicago Center, University of Illinois Chicago , Chicago, IL,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9045-0133","authenticated-orcid":false,"given":"Steven M","family":"Rowe","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham , Birmingham, AL,","place":["United States"]},{"name":"Cystic Fibrosis Foundation , Bethesda, MD,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0619-5799","authenticated-orcid":false,"given":"Benjamin M","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Medicine, McGill University , Montreal, Quebec,","place":["Canada"]},{"name":"Department of Medicine, Columbia University , New York, NY,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sundeep","family":"Salvi","sequence":"additional","affiliation":[{"name":"Pulmocare Research and Education Foundation , Pune,","place":["India"]},{"name":"Symbiosis Medical College for Women & Symbiosis University Hospital and Research Centre, Symbiosis International (Deemed University) , Pune,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Soler","sequence":"additional","affiliation":[{"name":"Pfizer, Cambridge, MA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jadwiga A","family":"Wedzicha","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute, Imperial College London , London,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7194-442X","authenticated-orcid":false,"given":"Jean A","family":"Wright","sequence":"additional","affiliation":[{"name":"COPD Foundation , Miami, FL,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3176-0603","authenticated-orcid":false,"given":"Prescott G","family":"Woodruff","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, University of California San Francisco , San Francisco, CA,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A","family":"Wise","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine , Baltimore, MD,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie","family":"Chang","sequence":"additional","affiliation":[{"name":"COPD Foundation , Miami, FL,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3904-3182","authenticated-orcid":false,"given":"Bruce E","family":"Miller","sequence":"additional","affiliation":[{"name":"COPD Foundation , Miami, FL,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3391-2490","authenticated-orcid":false,"given":"Courtney","family":"Crim","sequence":"additional","affiliation":[{"name":"COPD Foundation , Miami, FL,","place":["United States"]},{"name":"Division of Pulmonary Diseases and Critical Care Medicine, University of North Carolina at Chapel Hill School of Medicine , Chapel Hill, NC,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6968-4610","authenticated-orcid":false,"given":"M Bradley","family":"Drummond","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Diseases and Critical Care Medicine, University of North Carolina at Chapel Hill School of Medicine , Chapel Hill, NC,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"American Thoracic Society Clinical Problems Assembly and the American Thoracic Society Drug\/Device Discovery and Development Committee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courtney","family":"Crim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M Bradley","family":"Drummond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce E","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nirupama","family":"Putcha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surya P","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Bon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Casaburi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie A","family":"Christenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James D","family":"Crapo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey L","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory B","family":"Diette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark T","family":"Dransfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle N","family":"Eakin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MeiLan K","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi","family":"Kalhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry A","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M","family":"Mannino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando J","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Montes de Oca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugh","family":"Musick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven M","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sundeep","family":"Salvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin M","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Soler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jadwiga A","family":"Wedzicha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean A","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prescott G","family":"Woodruff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A","family":"Wise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,2,11]]},"reference":[{"key":"2026050720452096800_aaoag034-B1","author":"Global Initiative for Chronic Obstructive Lung Disease (GOLD)","year":"2025"},{"key":"2026050720452096800_aaoag034-B2","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1164\/rccm.202307-1203OC","article-title":"Structural predictors of lung function decline in young smokers with normal spirometry","volume":"209","author":"Ritchie","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"2026050720452096800_aaoag034-B3","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1056\/NEJMoa1505971","article-title":"Clinical significance of symptoms in smokers with preserved pulmonary function","volume":"374","author":"Woodruff","year":"2016","journal-title":"N Engl J Med"},{"key":"2026050720452096800_aaoag034-B4","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1001\/jama.2020.6918","article-title":"Association of dysanapsis with chronic obstructive pulmonary disease among older adults","volume":"323","author":"Smith","year":"2020","journal-title":"JAMA"},{"key":"2026050720452096800_aaoag034-B5","author":"Global Initiative for Chronic Obstructive Lung Disease (GOLD)","year":"2023"},{"key":"2026050720452096800_aaoag034-B6","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1164\/rccm.202311-2180PP","article-title":"Call to action: how can we promote the development of new pharmacologic treatments in chronic obstructive pulmonary disease?","volume":"210","author":"Belz","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"2026050720452096800_aaoag034-B7","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1164\/rccm.201710-2028PP","article-title":"At the root: defining and halting progression of early chronic obstructive pulmonary disease","volume":"197","author":"Martinez","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"2026050720452096800_aaoag034-B8","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1164\/rccm.202208-1569OC","article-title":"Longitudinal asthma phenotypes from childhood to middle-age: a population-based cohort study","volume":"208","author":"Tan","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2026050720452096800_aaoag034-B9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1411532","article-title":"Lung-function trajectories leading to chronic obstructive pulmonary disease","volume":"373","author":"Lange","year":"2015","journal-title":"N Engl J Med"},{"key":"2026050720452096800_aaoag034-B10","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S2213-2600(25)00043-8","article-title":"General population-based lung function trajectories over the life course: an accelerated cohort study","volume":"13","author":"Garcia-Aymerich","year":"2025","journal-title":"Lancet Respir Med"},{"key":"2026050720452096800_aaoag034-B11","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.rmed.2019.06.003","article-title":"Age- and gender-specific incidence of new asthma diagnosis from childhood to late adulthood","volume":"154","author":"Honkam\u00e4ki","year":"2019","journal-title":"Respir Med"},{"key":"2026050720452096800_aaoag034-B12","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1513\/AnnalsATS.201212-115OC","article-title":"Adult-onset asthma becomes the dominant phenotype among women by age 40 years. The longitudinal CARDIA study","volume":"10","author":"Sood","year":"2013","journal-title":"Ann Am Thorac Soc"},{"key":"2026050720452096800_aaoag034-B13","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.2337\/dc22-S002","article-title":"2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes\u20142022","volume":"45","author":"American Diabetes Association Professional Practice Committee","year":"2022","journal-title":"Diabetes Care"},{"key":"2026050720452096800_aaoag034-B14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1164\/rccm.200901-0047OC","article-title":"The natural history of chronic airflow obstruction revisited: an analysis of the Framingham Offspring Cohort","volume":"180","author":"Kohansal","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"2026050720452096800_aaoag034-B15","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S2213-2600(21)00506-3","article-title":"Chronic obstructive pulmonary disease in never-smokers: risk factors, pathogenesis, and implications for prevention and treatment","volume":"10","author":"Yang","year":"2022","journal-title":"Lancet Respir Med"},{"key":"2026050720452096800_aaoag034-B16","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1056\/NEJM197806082982303","article-title":"The relations between structural changes in small airways and pulmonary-function tests","volume":"298","author":"Cosio","year":"1978","journal-title":"N Engl J Med"},{"key":"2026050720452096800_aaoag034-B17","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1056\/NEJMoa032158","article-title":"The nature of small-airway obstruction in chronic obstructive pulmonary disease","volume":"350","author":"Hogg","year":"2004","journal-title":"N Engl J Med"},{"key":"2026050720452096800_aaoag034-B18","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.rmed.2012.04.010","article-title":"Impulse oscillometry may be of value in detecting early manifestations of COPD","volume":"106","author":"Frantz","year":"2012","journal-title":"Respir Med"},{"key":"2026050720452096800_aaoag034-B19","doi-asserted-by":"publisher","first-page":"00066","DOI":"10.1183\/23120541.00066-2016","article-title":"Distal airway dysfunction identifies pulmonary inflammation in asymptomatic smokers","volume":"2","author":"Berger","year":"2016","journal-title":"ERJ Open Res"},{"key":"2026050720452096800_aaoag034-B20","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1164\/rccm.202306-0975OC","article-title":"Diagnostic potential of oscillometry: a population-based approach","volume":"209","author":"Veneroni","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"2026050720452096800_aaoag034-B21","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1164\/rccm.202501-0028OC","article-title":"Oscillometry-defined small airway dysfunction in tobacco-exposed adults with impaired or preserved airflow","volume":"211","author":"Abdo","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"key":"2026050720452096800_aaoag034-B22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s12576-014-0329-4","article-title":"Comparison of two devices for respiratory impedance measurement using a forced oscillation technique: basic study using phantom models","volume":"64","author":"Tanimura","year":"2014","journal-title":"J Physiol Sci"},{"key":"2026050720452096800_aaoag034-B23","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1183\/09031936.01.00046401","article-title":"Evaluation of impulse oscillation system: comparison with forced oscillation technique and body plethysmography","volume":"18","author":"Hellinckx","year":"2001","journal-title":"Eur Respir J"},{"key":"2026050720452096800_aaoag034-B24","doi-asserted-by":"publisher","first-page":"11618","DOI":"10.1038\/s41598-019-48039-x","article-title":"Oscillometry in chronic obstructive lung disease: in vitro and in vivo evaluation of the impulse oscillometry and tremoflo devices","volume":"9","author":"Lundblad","year":"2019","journal-title":"Sci Rep"},{"key":"2026050720452096800_aaoag034-B25","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1164\/rccm.202312-2222LE","article-title":"Z-scores or fixed cutoff values to interpret oscillometry: opportunities from the LEAD study","volume":"209","author":"Salvi","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"2026050720452096800_aaoag034-B26","doi-asserted-by":"publisher","first-page":"1900753","DOI":"10.1183\/13993003.00753-2019","article-title":"Technical standards for respiratory oscillometry","volume":"55","author":"King","year":"2020","journal-title":"Eur Respir J"},{"key":"2026050720452096800_aaoag034-B27","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1152\/jappl.1997.83.6.1907","article-title":"Ventilation distribution during histamine provocation","volume":"83","author":"Verbanck","year":"1997","journal-title":"J Appl Physiol (1985)"},{"key":"2026050720452096800_aaoag034-B28","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1164\/rccm.200401-037OC","article-title":"Noninvasive assessment of airway alterations in smokers: the small airways revisited","volume":"170","author":"Verbanck","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"2026050720452096800_aaoag034-B29","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/resp.13215","article-title":"Peripheral airway dysfunction and relationship with symptoms in smokers with preserved spirometry","volume":"23","author":"Jetmalani","year":"2018","journal-title":"Respirology"},{"key":"2026050720452096800_aaoag034-B30","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1152\/japplphysiol.00326.2018","article-title":"Difference between SF6 and N2 multiple breath washout kinetics is due to N2 back diffusion and error in N2 offset","volume":"125","author":"Guglani","year":"2018","journal-title":"J Appl Physiol (1985)"},{"key":"2026050720452096800_aaoag034-B31","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1183\/09031936.00069712","article-title":"Consensus statement for inert gas washout measurement using multiple- and single- breath tests","volume":"41","author":"Robinson","year":"2013","journal-title":"Eur Respir J"},{"key":"2026050720452096800_aaoag034-B32","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1164\/rccm.202212-2330OC","article-title":"Can we use lung function thresholds and respiratory symptoms to identify pre-chronic obstructive pulmonary disease? A prospective, population-based cohort study","volume":"209","author":"Tan","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"2026050720452096800_aaoag034-B33","doi-asserted-by":"publisher","first-page":"100984","DOI":"10.1016\/j.lanwpc.2023.100984","article-title":"Potential pre-COPD indicators in association with COPD development and COPD prediction models in Chinese: a prospective cohort study","volume":"44","author":"Fan","year":"2024","journal-title":"Lancet Reg Health West Pac"},{"key":"2026050720452096800_aaoag034-B34","doi-asserted-by":"publisher","first-page":"00624","DOI":"10.1183\/23120541.00624-2024","article-title":"Optimal spirometry thresholds for the prediction of chronic airflow obstruction: a multinational longitudinal study","volume":"11","author":"Lam","year":"2025","journal-title":"ERJ Open Res"},{"key":"2026050720452096800_aaoag034-B35","doi-asserted-by":"publisher","first-page":"2300806","DOI":"10.1183\/13993003.00806-2023","article-title":"From pre-COPD to COPD: a simple, low cost and easy to IMplement (SLIM) risk calculator","volume":"62","author":"Divo","year":"2023","journal-title":"Eur Respir J"},{"key":"2026050720452096800_aaoag034-B36","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1378\/chest.129.2.369","article-title":"Discriminating measures and normal values for expiratory obstruction","volume":"129","author":"Hansen","year":"2006","journal-title":"Chest"},{"key":"2026050720452096800_aaoag034-B37","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1183\/09031936.00080312","article-title":"Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations","volume":"40","author":"Quanjer","year":"2012","journal-title":"Eur Respir J"},{"key":"2026050720452096800_aaoag034-B38","doi-asserted-by":"publisher","first-page":"111","DOI":"10.15326\/jcopdf.2021.0241","article-title":"Forced expiratory flow at 25%-75% links COPD physiology to emphysema and disease severity in the SPIROMICS cohort","volume":"9","author":"Ronish","year":"2022","journal-title":"Chronic Obstr Pulm Dis"},{"key":"2026050720452096800_aaoag034-B39","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1164\/ajrccm.162.3.9907115","article-title":"FEV(6) is an acceptable surrogate for FVC in the spirometric diagnosis of airway obstruction and restriction","volume":"162","author":"Swanney","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"2026050720452096800_aaoag034-B40","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.chest.2021.10.046","article-title":"Significance of FEV3\/FEV6 in recognition of early airway disease in smokers at risk of development of COPD: analysis of the SPIROMICS cohort","volume":"161","author":"Yee","year":"2022","journal-title":"Chest"},{"key":"2026050720452096800_aaoag034-B41","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.chest.2016.06.047","article-title":"A novel spirometric measure identifies mild COPD unidentified by standard criteria","volume":"150","author":"Dilektasli","year":"2016","journal-title":"Chest"},{"key":"2026050720452096800_aaoag034-B42","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1513\/AnnalsATS.201308-251OC","article-title":"FEV(1)\/FEV(6) to diagnose airflow obstruction. Comparisons with computed tomography and morbidity indices","volume":"11","author":"Bhatt","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"2026050720452096800_aaoag034-B43","doi-asserted-by":"publisher","first-page":"17484","DOI":"10.1038\/s41598-018-35930-2","article-title":"New spirometry indices for detecting mild airflow obstruction","volume":"8","author":"Bhatt","year":"2018","journal-title":"Sci Rep"},{"key":"2026050720452096800_aaoag034-B44","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1513\/AnnalsATS.202209-816OC","article-title":"Parameter D: new measure of airflow obstruction","volume":"20","author":"Bhatt","year":"2023","journal-title":"Ann Am Thorac Soc"},{"key":"2026050720452096800_aaoag034-B45","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.2147\/COPD.S406208","article-title":"Trajectories of spirometric patterns, obstructive and PRISm, in a population-based cohort in Latin America","volume":"18","author":"Perez-Padilla","year":"2023","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026050720452096800_aaoag034-B46","doi-asserted-by":"publisher","first-page":"14799731241312687","DOI":"10.1177\/14799731241312687","article-title":"Prevalence and characteristics of adults with preserved ratio impaired spirometry (PRISm): data from the BOLD Australia study","volume":"22","author":"Zhou","year":"2025","journal-title":"Chron Respir Dis"},{"key":"2026050720452096800_aaoag034-B47","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1001\/jama.2021.20939","article-title":"Association between preserved ratio impaired spirometry and clinical outcomes in US adults","volume":"326","author":"Wan","year":"2021","journal-title":"JAMA"},{"key":"2026050720452096800_aaoag034-B48","doi-asserted-by":"publisher","first-page":"1901217","DOI":"10.1183\/13993003.01217-2019","article-title":"Trajectory and mortality of preserved ratio impaired spirometry: the Rotterdam study","volume":"55","author":"Wijnant","year":"2020","journal-title":"Eur Respir J"},{"key":"2026050720452096800_aaoag034-B49","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1164\/rccm.202401-0042ED","article-title":"Should the term \u201cPRISm\u201d be restricted to use in evaluating smokers?","volume":"209","author":"Casaburi","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"2026050720452096800_aaoag034-B50","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.chest.2021.09.021","article-title":"Significant spirometric transitions and preserved ratio impaired spirometry among ever smokers","volume":"161","author":"Wan","year":"2022","journal-title":"Chest"},{"key":"2026050720452096800_aaoag034-B51","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1183\/09031936.00020714","article-title":"Airway wall thickness associated with forced expiratory volume in 1 second decline and development of airflow limitation","volume":"45","author":"Mohamed Hoesein","year":"2015","journal-title":"Eur Respir J"},{"key":"2026050720452096800_aaoag034-B52","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1513\/AnnalsATS.201710-820OC","article-title":"Prognostic significance of large airway dimensions on computed tomography in the general population. The Multi-Ethnic Study of Atherosclerosis (MESA) lung study","volume":"15","author":"Oelsner","year":"2018","journal-title":"Ann Am Thorac Soc"},{"key":"2026050720452096800_aaoag034-B53","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1056\/NEJMoa1106955","article-title":"Small-airway obstruction and emphysema in chronic obstructive pulmonary disease","volume":"365","author":"McDonough","year":"2011","journal-title":"N Engl J Med"},{"key":"2026050720452096800_aaoag034-B54","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1038\/nm.2971","article-title":"Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression","volume":"18","author":"Galb\u00e1n","year":"2012","journal-title":"Nat Med"},{"key":"2026050720452096800_aaoag034-B55","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1164\/rccm.201811-2083OC","article-title":"Noninvasive imaging biomarker identifies small airway damage in severe chronic obstructive pulmonary disease","volume":"200","author":"Vasilescu","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2026050720452096800_aaoag034-B56","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1164\/rccm.201511-2219OC","article-title":"Association between functional small airway disease and FEV1 decline in chronic obstructive pulmonary disease","volume":"194","author":"Bhatt","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"2026050720452096800_aaoag034-B57","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.acra.2018.05.024","article-title":"Voxel-wise longitudinal parametric response mapping analysis of chest computed tomography in smokers","volume":"26","author":"Labaki","year":"2019","journal-title":"Acad Radiol"},{"key":"2026050720452096800_aaoag034-B58","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/s12931-019-1237-1","article-title":"Relationship between diffusion capacity and small airway abnormality in COPDGene","volume":"20","author":"Criner","year":"2019","journal-title":"Respir Res"},{"key":"2026050720452096800_aaoag034-B59","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1164\/rccm.202209-1698PP","article-title":"Repeatability of pulmonary quantitative computed tomography measurements in chronic obstructive pulmonary disease","volume":"208","author":"Motahari","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2026050720452096800_aaoag034-B60","doi-asserted-by":"publisher","first-page":"138","DOI":"10.18383\/j.tom.2017.00013","article-title":"Correcting nonpathological variation in longitudinal parametric response maps of CT scans in COPD subjects: SPIROMICS","volume":"3","author":"Fern\u00e1ndez-Baldera","year":"2017","journal-title":"Tomography"},{"key":"2026050720452096800_aaoag034-B61","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2147\/COPD.S96809","article-title":"Association of incidental emphysema with annual lung function decline and future development of airflow limitation","volume":"11","author":"Koo","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026050720452096800_aaoag034-B62","doi-asserted-by":"publisher","first-page":"204","DOI":"10.15326\/jcopdf.2.3.2014.0154","article-title":"Correlation between emphysema and lung function in healthy smokers and smokers with COPD","volume":"2","author":"Thomsen","year":"2015","journal-title":"Chronic Obstr Pulm Dis"},{"key":"2026050720452096800_aaoag034-B63","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1136\/thx.2010.145995","article-title":"CT-quantified emphysema in male heavy smokers: association with lung function decline","volume":"66","author":"Mohamed Hoesein","year":"2011","journal-title":"Thorax"},{"key":"2026050720452096800_aaoag034-B64","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1183\/09031936.00186311","article-title":"Computed tomography-quantified emphysema distribution is associated with lung function decline","volume":"40","author":"Mohamed Hoesein","year":"2012","journal-title":"Eur Respir J"},{"key":"2026050720452096800_aaoag034-B65","doi-asserted-by":"publisher","first-page":"e93221","DOI":"10.1371\/journal.pone.0093221","article-title":"Emphysema predicts hospitalisation and incident airflow obstruction among older smokers: a prospective cohort study","volume":"9","author":"McAllister","year":"2014","journal-title":"PLoS One"},{"key":"2026050720452096800_aaoag034-B66","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1513\/AnnalsATS.201810-669OC","article-title":"Using novel computed tomography analysis to describe the contribution and distribution of emphysema and small airways disease in chronic obstructive pulmonary disease","volume":"16","author":"Ostridge","year":"2019","journal-title":"Ann Am Thorac Soc"},{"key":"2026050720452096800_aaoag034-B67","doi-asserted-by":"publisher","first-page":"EVIDoa2400424","DOI":"10.1056\/EVIDoa2400424","article-title":"Prevalence and prognostic significance of COPD in adults younger than 50 years of age","volume":"4","author":"Diaz","year":"2025","journal-title":"NEJM Evid"},{"key":"2026050720452096800_aaoag034-B68","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1001\/jamainternmed.2020.0104","article-title":"Association of nonobstructive chronic bronchitis with respiratory health outcomes in adults","volume":"180","author":"Balte","year":"2020","journal-title":"JAMA Internal Medicine"},{"key":"2026050720452096800_aaoag034-B69","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.rmed.2013.11.003","article-title":"The clinical impact of non-obstructive chronic bronchitis in current and former smokers","volume":"108","author":"Martinez","year":"2014","journal-title":"Respir Med"},{"key":"2026050720452096800_aaoag034-B70","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1056\/NEJMoa2204752","article-title":"Bronchodilators in tobacco-exposed persons with symptoms and preserved lung function","volume":"387","author":"Han","year":"2022","journal-title":"N Engl J Med"},{"key":"2026050720452096800_aaoag034-B71","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12931-024-02672-x","article-title":"Eligibility of patients with chronic obstructive pulmonary disease for inclusion in randomised control trials investigating triple therapy: a study using routinely collected data","volume":"25","author":"Whittaker","year":"2024","journal-title":"Respir Res"},{"key":"2026050720452096800_aaoag034-B72","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1164\/rccm.202204-0688ED","article-title":"Understanding the people excluded from chronic obstructive pulmonary disease clinical trials","volume":"206","author":"Krishnan","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"2026050720452096800_aaoag034-B73","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1164\/rccm.202303-0400SO","article-title":"An update on outcomes for COPD pharmacological trials: a COPD investigators report - reassessment of the 2008 American Thoracic Society\/European Respiratory Society statement on outcomes for COPD pharmacological trials","volume":"208","author":"Cazzola","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2026050720452096800_aaoag034-B74","author":"FDA C","year":"2022"},{"key":"2026050720452096800_aaoag034-B75","author":"FDA C","year":"2023"},{"key":"2026050720452096800_aaoag034-B76","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1183\/09031936.00099306","article-title":"Outcomes for COPD pharmacological trials: from lung function to biomarkers","volume":"31","author":"Cazzola","year":"2008","journal-title":"Eur Respir J"},{"key":"2026050720452096800_aaoag034-B77","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12931-020-01431-y","article-title":"Composite endpoints in COPD: clinically important deterioration in the UPLIFT trial","volume":"21","author":"Rabe","year":"2020","journal-title":"Respir Res"},{"key":"2026050720452096800_aaoag034-B78","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1080\/15412550802363386","article-title":"A review of the role of FEV1 in the COPD paradigm","volume":"5","author":"Doherty","year":"2008","journal-title":"COPD"},{"key":"2026050720452096800_aaoag034-B79","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41533-021-00236-w","article-title":"Pulmonary function testing in COPD: looking beyond the curtain of FEV1","volume":"31","author":"Kakavas","year":"2021","journal-title":"NPJ Prim Care Respir Med"},{"key":"2026050720452096800_aaoag034-B80","doi-asserted-by":"publisher","first-page":"210208","DOI":"10.1183\/16000617.0208-2021","article-title":"Clinical significance and applications of oscillometry","volume":"31","author":"Kaminsky","year":"2022","journal-title":"Eur Respir Rev"},{"key":"2026050720452096800_aaoag034-B81","doi-asserted-by":"publisher","first-page":"14799731211056340","DOI":"10.1177\/14799731211056340","article-title":"Diffusing capacity in chronic obstructive pulmonary disease assessment: a meta-analysis","volume":"18","author":"Ni","year":"2021","journal-title":"Chron Respir Dis"},{"key":"2026050720452096800_aaoag034-B82","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1164\/rccm.202311-2145OC","article-title":"Application of the European Respiratory Society\/American Thoracic Society spirometry standards and race-neutral equations in the COPDGene study","volume":"210","author":"Schiavi","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"2026050720452096800_aaoag034-B83","doi-asserted-by":"publisher","first-page":"107557","DOI":"10.1016\/j.rmed.2024.107557","article-title":"Predicting exacerbations in COPD in the Danish general population","volume":"224","author":"Marott","year":"2024","journal-title":"Respir Med"},{"key":"2026050720452096800_aaoag034-B84","doi-asserted-by":"publisher","first-page":"00047","DOI":"10.1183\/23120541.00047-2020","article-title":"Phenotypic characterisation of early COPD: a prospective case-control study","volume":"6","author":"Cos\u00edo","year":"2020","journal-title":"ERJ Open Res"},{"key":"2026050720452096800_aaoag034-B85","doi-asserted-by":"publisher","first-page":"2201793","DOI":"10.1183\/13993003.01793-2022","article-title":"Minimal clinically important difference for impulse oscillometry in adults with asthma","volume":"61","author":"Abdo","year":"2023","journal-title":"Eur Respir J"},{"key":"2026050720452096800_aaoag034-B86","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1164\/rccm.202006-2433OC","article-title":"Lung clearance index to track acute respiratory events in school-age children with cystic fibrosis","volume":"203","author":"Perrem","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"2026050720452096800_aaoag034-B87","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jcf.2013.09.005","article-title":"Lung clearance index: evidence for use in clinical trials in cystic fibrosis","volume":"13","author":"Kent","year":"2014","journal-title":"J Cyst Fibros"},{"key":"2026050720452096800_aaoag034-B88","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1164\/rccm.201509-1722PP","article-title":"Plasma fibrinogen qualification as a drug development tool in chronic obstructive pulmonary disease. Perspective of the chronic obstructive pulmonary disease biomarker qualification consortium","volume":"193","author":"Miller","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"2026050720452096800_aaoag034-B89","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/S0140-6736(15)60860-1","article-title":"Intravenous augmentation treatment and lung density in severe \u03b11 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial","volume":"386","author":"Chapman","year":"2015","journal-title":"Lancet"},{"key":"2026050720452096800_aaoag034-B90","author":"FDA-NIH Biomarker Working Group","year":"2016"},{"key":"2026050720452096800_aaoag034-B91","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1136\/thorax-2022-219039","article-title":"Frequency and severity of respiratory infections prior to COPD diagnosis and risk of subsequent postdiagnosis COPD exacerbations and mortality: EXACOS-UK health care data study","volume":"78","author":"Whittaker","year":"2023","journal-title":"Thorax"},{"key":"2026050720452096800_aaoag034-B92","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s41687-021-00399-7","article-title":"Developing a patient-driven chronic obstructive pulmonary disease (COPD) research agenda in the U.S","volume":"5","author":"Gru\u00df","year":"2021","journal-title":"J Patient Rep Outcomes"},{"key":"2026050720452096800_aaoag034-B93","doi-asserted-by":"publisher","first-page":"00686","DOI":"10.1183\/23120541.00686-2021","article-title":"People living with moderate-to-severe COPD prefer improvement of daily symptoms over the improvement of exacerbations: a multicountry patient preference study","volume":"8","author":"Cook","year":"2022","journal-title":"ERJ Open Res"},{"key":"2026050720452096800_aaoag034-B94","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1164\/rccm.201508-1653OC","article-title":"The 6-minute-walk distance test as a chronic obstructive pulmonary disease stratification tool. Insights from the COPD biomarker qualification consortium","volume":"194","author":"Celli","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"2026050720452096800_aaoag034-B95","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1136\/thx.54.3.213","article-title":"The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary disease","volume":"54","author":"Revill","year":"1999","journal-title":"Thorax"},{"key":"2026050720452096800_aaoag034-B96","doi-asserted-by":"publisher","first-page":"520","DOI":"10.15326\/jcopdf.2022.0331","article-title":"Endurance time during constant work rate cycle ergometry in COPD: development of an integrated database from interventional studies","volume":"9","author":"Casaburi","year":"2022","journal-title":"Chronic Obstr Pulm Dis"},{"key":"2026050720452096800_aaoag034-B97","doi-asserted-by":"publisher","first-page":"252","DOI":"10.15326\/jcopdf.2021.0258","article-title":"A conceptual framework for use of increased endurance time during constant work rate cycle ergometry as a patient-focused meaningful outcome in COPD clinical trials","volume":"9","author":"Casaburi","year":"2022","journal-title":"Chronic Obstr Pulm Dis"},{"key":"2026050720452096800_aaoag034-B98","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1183\/09031936.00183014","article-title":"The PROactive instruments to measure physical activity in patients with chronic obstructive pulmonary disease","volume":"46","author":"Gimeno-Santos","year":"2015","journal-title":"Eur Respir J"},{"key":"2026050720452096800_aaoag034-B99","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1081\/copd-200050666","article-title":"The MCID of the transition dyspnea index is a total score of one unit","volume":"2","author":"Mahler","year":"2005","journal-title":"COPD"},{"key":"2026050720452096800_aaoag034-B100","doi-asserted-by":"publisher","first-page":"551","DOI":"10.15326\/jcopdf.2021.0235","article-title":"Use of the evaluating respiratory SymptomsTM in COPD as an outcome measure in clinical trials: a rapid systematic review","volume":"8","author":"Bushnell","year":"2021","journal-title":"Chronic Obstr Pulm Dis"},{"key":"2026050720452096800_aaoag034-B101","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.4187\/respcare.08889","article-title":"Modified medical research council and COPD assessment test cutoff points","volume":"66","author":"Munari","year":"2021","journal-title":"Respir Care"},{"key":"2026050720452096800_aaoag034-B102","first-page":"109","article-title":"The COPD biomarkers qualification consortium St George\u2019s Respiratory Questionnaire manuscripts: output of a consortium to advance drug development","volume":"4","author":"Tabberer","year":"2017","journal-title":"Chronic Obstr Pulm Dis"},{"key":"2026050720452096800_aaoag034-B103","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1183\/09031936.00102509","article-title":"Development and first validation of the COPD assessment test","volume":"34","author":"Jones","year":"2009","journal-title":"Eur Respir J"},{"key":"2026050720452096800_aaoag034-B104","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1164\/rccm.201005-0762OC","article-title":"Standardizing measurement of chronic obstructive pulmonary disease exacerbations. Reliability and validity of a patient-reported diary","volume":"183","author":"Leidy","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026050720452096800_aaoag034-B105","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12931-023-02394-6","article-title":"Chronic airways assessment test: psychometric properties in patients with asthma and\/or COPD","volume":"24","author":"Tomaszewski","year":"2023","journal-title":"Respir Res"},{"key":"2026050720452096800_aaoag034-B106","doi-asserted-by":"publisher","first-page":"107054","DOI":"10.1016\/j.rmed.2022.107054","article-title":"Clinically important deterioration: a composite tool for managing patients with COPD","volume":"205","author":"Cazzola","year":"2022","journal-title":"Respir Med"},{"key":"2026050720452096800_aaoag034-B107","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1164\/rccm.202406-1254CI","article-title":"Is disease stability an attainable chronic obstructive pulmonary disease treatment goal?","volume":"211","author":"Singh","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"key":"2026050720452096800_aaoag034-B108","doi-asserted-by":"publisher","first-page":"105429","DOI":"10.1016\/j.ebiom.2024.105429","article-title":"Polygenic and transcriptional risk scores identify chronic obstructive pulmonary disease subtypes in the COPDGene and ECLIPSE cohort studies","volume":"110","author":"Moll","year":"2024","journal-title":"EBioMedicine"},{"key":"2026050720452096800_aaoag034-B109","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S2213-2600(24)00038-9","article-title":"MACE in COPD: addressing cardiopulmonary risk","volume":"12","author":"Hurst","year":"2024","journal-title":"Lancet Respir Med"},{"key":"2026050720452096800_aaoag034-B110","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1465-9921-12-18","article-title":"Reduction of exacerbations by the PDE4 inhibitor roflumilast\u2014the importance of defining different subsets of patients with COPD","volume":"12","author":"Rennard","year":"2011","journal-title":"Respir Res"},{"key":"2026050720452096800_aaoag034-B111","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1056\/NEJMoa0900928","article-title":"A randomized study of endobronchial valves for advanced emphysema","volume":"363","author":"Sciurba","year":"2010","journal-title":"N Engl J Med"},{"key":"2026050720452096800_aaoag034-B112","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/S2213-2600(23)00261-8","article-title":"COPD and multimorbidity: recognising and addressing a syndemic occurrence","volume":"11","author":"Fabbri","year":"2023","journal-title":"Lancet Respir Med"},{"key":"2026050720452096800_aaoag034-B113","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1164\/rccm.202306-0944OC","article-title":"Ensifentrine, a novel phosphodiesterase 3 and 4 inhibitor for the treatment of chronic obstructive pulmonary disease: randomized, double-blind, placebo-controlled, multicenter phase III trials (the ENHANCE trials)","volume":"208","author":"Anzueto","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2026050720452096800_aaoag034-B114","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1056\/NEJMoa2303951","article-title":"Dupilumab for COPD with type 2 inflammation indicated by eosinophil counts","volume":"389","author":"Bhatt","year":"2023","journal-title":"N Engl J Med"},{"key":"2026050720452096800_aaoag034-B115","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1001\/jama.2024.24212","article-title":"Polygenic risk score added to conventional case finding to identify undiagnosed chronic obstructive pulmonary disease","volume":"333","author":"Zhang","year":"2025","journal-title":"JAMA"},{"key":"2026050720452096800_aaoag034-B116","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/S2213-2600(19)30397-2","article-title":"The Acute COPD Exacerbation Prediction Tool (ACCEPT): a modelling study","volume":"8","author":"Adibi","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2026050720452096800_aaoag034-B117","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1513\/AnnalsATS.202109-1020OC","article-title":"Pooled cohort probability score for subclinical airflow obstruction","volume":"19","author":"Bhatt","year":"2022","journal-title":"Ann Am Thorac Soc"},{"key":"2026050720452096800_aaoag034-B118","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1016\/j.jacc.2019.03.010","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease","volume":"74","author":"Arnett","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026050720452096800_aaoag034-B119","doi-asserted-by":"publisher","first-page":"3855","DOI":"10.3390\/jcm13133855","article-title":"CRP, fibrinogen, white blood cells, and blood cell indices as prognostic biomarkers of future COPD exacerbation frequency: the TIE cohort study","volume":"13","author":"Ellingsen","year":"2024","journal-title":"J Clin Med"},{"key":"2026050720452096800_aaoag034-B120","doi-asserted-by":"publisher","first-page":"e46207","DOI":"10.1371\/journal.pone.0046207","article-title":"Repeatability of and relationship between potential COPD biomarkers in bronchoalveolar lavage, bronchial biopsies, serum, and induced sputum","volume":"7","author":"R\u00f6pcke","year":"2012","journal-title":"PLoS One"},{"key":"2026050720452096800_aaoag034-B121","doi-asserted-by":"publisher","first-page":"3786","DOI":"10.3390\/ijms24043786","article-title":"Matrix metalloproteinases in chronic obstructive pulmonary disease","volume":"24","author":"Christopoulou","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2026050720452096800_aaoag034-B122","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1164\/rccm.201912-2384PP","article-title":"Blood eosinophil counts in clinical trials for chronic obstructive pulmonary disease","volume":"202","author":"Singh","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2026050720452096800_aaoag034-B123","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/S2213-2600(19)30190-0","article-title":"Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial","volume":"7","author":"Pascoe","year":"2019","journal-title":"Lancet Respir Med"},{"key":"2026050720452096800_aaoag034-B124","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.2147\/COPD.S374670","article-title":"Benefits of budesonide\/glycopyrronium\/formoterol fumarate dihydrate on COPD exacerbations, lung function, symptoms, and quality of life across blood eosinophil ranges: a post-hoc analysis of data from ETHOS","volume":"17","author":"Bafadhel","year":"2022","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026050720452096800_aaoag034-B125","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.2147\/COPD.S366911","article-title":"Association of airway eosinophilia with small airway dysfunction in patients with mild and at risk for COPD","volume":"17","author":"Abdo","year":"2022","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026050720452096800_aaoag034-B126","doi-asserted-by":"publisher","first-page":"00438","DOI":"10.1183\/23120541.00438-2024","article-title":"Delaying disease progression in COPD with early escalation to triple therapy: a modelling study (DEPICT-2)","volume":"11","author":"Singh","year":"2025","journal-title":"ERJ Open Res"},{"key":"2026050720452096800_aaoag034-B127","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/S2213-2600(20)30101-6","article-title":"Chronic obstructive pulmonary disease and related phenotypes: polygenic risk scores in population-based and case-control cohorts","volume":"8","author":"Moll","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2026050720452096800_aaoag034-B128","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1164\/rccm.201103-0568OC","article-title":"New Mexican Hispanic smokers have lower odds of chronic obstructive pulmonary disease and less decline in lung function than non-Hispanic whites","volume":"184","author":"Bruse","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026050720452096800_aaoag034-B129","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3390\/diagnostics11040599","article-title":"Genetic factors associated with COPD depend on the ancestral Caucasian\/Amerindian component in the Mexican population","volume":"11","author":"P\u00e9rez-Rubio","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"2026050720452096800_aaoag034-B130","doi-asserted-by":"publisher","first-page":"240019","DOI":"10.1183\/16000617.0019-2024","article-title":"Breathing new life into the study of COPD with genes identified from genome-wide association studies","volume":"33","author":"Werder","year":"2024","journal-title":"Eur Respir Rev"},{"key":"2026050720452096800_aaoag034-B131","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1165\/rcmb.2022-0302OC","article-title":"Integrating genetics, transcriptomics, and proteomics in lung tissue to investigate chronic obstructive pulmonary disease","volume":"68","author":"Zhang","year":"2023","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026050720452096800_aaoag034-B132","doi-asserted-by":"publisher","first-page":"11106","DOI":"10.3390\/ijms252011106","article-title":"Multi-omics analysis identified drug repurposing targets for chronic obstructive pulmonary disease","volume":"25","author":"Wang","year":"2024","journal-title":"Int J Mol Sci"},{"key":"2026050720452096800_aaoag034-B133","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1038\/s41396-020-0727-y","article-title":"Multi-omic meta-analysis identifies functional signatures of airway microbiome in chronic obstructive pulmonary disease","volume":"14","author":"Wang","year":"2020","journal-title":"ISME J"},{"key":"2026050720452096800_aaoag034-B134","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1164\/rccm.202301-0132OC","article-title":"Small airway disease in pre-chronic obstructive pulmonary disease with emphysema: a cross-sectional study","volume":"209","author":"Verleden","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"2026050720452096800_aaoag034-B135","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1136\/thorax-2023-220972","article-title":"Type-2 inflammation and lung function decline in chronic airway disease in the general population","volume":"79","author":"\u00c7olak","year":"2024","journal-title":"Thorax"},{"key":"2026050720452096800_aaoag034-B136","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1007\/s00134-020-05934-6","article-title":"Contemporary strategies to improve clinical trial design for critical care research: insights from the first critical care clinical trialists workshop","volume":"46","author":"Harhay","year":"2020","journal-title":"Intensive Care Med"},{"key":"2026050720452096800_aaoag034-B137","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/nrd1927","article-title":"Bayesian clinical trials","volume":"5","author":"Berry","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"2026050720452096800_aaoag034-B138","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1111\/resp.14337","article-title":"Bayesian adaptive clinical trial designs for respiratory medicine","volume":"27","author":"Ryan","year":"2022","journal-title":"Respirology"},{"key":"2026050720452096800_aaoag034-B139","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/S0140-6736(24)01295-9","article-title":"Bayesian statistics for clinical research","volume":"404","author":"Goligher","year":"2024","journal-title":"Lancet"},{"key":"2026050720452096800_aaoag034-B140","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/10543400600614742","article-title":"Adaptive designs in clinical drug development\u2014an executive summary of the PhRMA working group","volume":"16","author":"Gallo","year":"2006","journal-title":"J Biopharm Stat"},{"key":"2026050720452096800_aaoag034-B141","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.pupt.2010.01.003","article-title":"Integrating indacaterol dose selection in a clinical study in COPD using an adaptive seamless design","volume":"23","author":"Barnes","year":"2010","journal-title":"Pulm Pharmacol Ther"},{"key":"2026050720452096800_aaoag034-B142","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1002\/sim.2022","article-title":"An experimental design for the development of adaptive treatment strategies","volume":"24","author":"Murphy","year":"2005","journal-title":"Stat Med"},{"key":"2026050720452096800_aaoag034-B143","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1001\/jama.2022.24324","article-title":"Sequential, multiple assignment, randomized trial designs","volume":"329","author":"Kidwell","year":"2023","journal-title":"JAMA"},{"key":"2026050720452096800_aaoag034-B144","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1056\/NEJMra1510062","article-title":"Master protocols to study multiple therapies, multiple diseases, or both","volume":"377","author":"Woodcock","year":"2017","journal-title":"N Engl J Med"},{"key":"2026050720452096800_aaoag034-B145","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/ana.26285","article-title":"Adaptive platform trials to transform amyotrophic lateral sclerosis therapy development","volume":"91","author":"Paganoni","year":"2022","journal-title":"Ann Neurol"},{"key":"2026050720452096800_aaoag034-B146","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","author":"Horby","year":"2021","journal-title":"N Engl J Med"},{"key":"2026050720452096800_aaoag034-B147","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/jama.2020.17022","article-title":"Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial","volume":"324","author":"Angus","year":"2020","journal-title":"JAMA"},{"key":"2026050720452096800_aaoag034-B148","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41573-019-0034-3","article-title":"Adaptive platform trials: definition, design, conduct and reporting considerations","volume":"18","author":"Adaptive Platform Trials Coalition","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"2026050720452096800_aaoag034-B149","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1001\/jama.2015.2316","article-title":"The platform trial: an efficient strategy for evaluating multiple treatments","volume":"313","author":"Berry","year":"2015","journal-title":"JAMA"},{"key":"2026050720452096800_aaoag034-B150","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1001\/jama.2024.19528","article-title":"Making pragmatic clinical trials more pragmatic","volume":"332","author":"Platt","year":"2024","journal-title":"JAMA"},{"key":"2026050720452096800_aaoag034-B151","doi-asserted-by":"publisher","first-page":"h2147","DOI":"10.1136\/bmj.h2147","article-title":"The PRECIS-2 tool: designing trials that are fit for purpose","volume":"350","author":"Loudon","year":"2015","journal-title":"BMJ"},{"key":"2026050720452096800_aaoag034-B152","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1001\/jamainternmed.2018.3321","article-title":"Assessment of pragmatism in recently published randomized clinical trials","volume":"178","author":"Janiaud","year":"2018","journal-title":"JAMA Intern Med"},{"key":"2026050720452096800_aaoag034-B153","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1097\/MLR.0000000000000949","article-title":"Exploring meaningful patient engagement in ADAPTABLE (aspirin dosing: a patient-centric trial assessing benefits and long-term effectiveness)","volume":"56 Suppl 10 Suppl 1","author":"Faulkner","year":"2018","journal-title":"Med Care"},{"key":"2026050720452096800_aaoag034-B154","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jbi.2017.05.003","article-title":"A pragmatic method for transforming clinical research data from the research electronic data capture \u201cREDCap\u201d to clinical data interchange standards consortium (CDISC) study data tabulation model (SDTM): development and evaluation of REDCap2SDTM","volume":"70","author":"Yamamoto","year":"2017","journal-title":"J Biomed Inform"},{"key":"2026050720452096800_aaoag034-B155","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1056\/NEJMoa1608033","article-title":"Effectiveness of fluticasone furoate-vilanterol for COPD in clinical practice","volume":"375","author":"Vestbo","year":"2016","journal-title":"N Engl J Med"},{"key":"2026050720452096800_aaoag034-B156","article-title":"Impact of the CAPTURE COPD screening tool in US primary care: a cluster randomized trial","author":"Martinez","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"2026050720452096800_aaoag034-B157","doi-asserted-by":"publisher","first-page":"60","DOI":"10.15326\/jcopdf.2020.0155","article-title":"Protocol summary of the COPD assessment in primary care to identify undiagnosed respiratory disease and exacerbation risk (CAPTURE) validation in primary care study","volume":"8","author":"Yawn","year":"2021","journal-title":"Chronic Obstr Pulm Dis"},{"key":"2026050720452096800_aaoag034-B158","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1001\/jama.2023.0128","article-title":"Discriminative accuracy of the CAPTURE tool for identifying chronic obstructive pulmonary disease in US primary care settings","volume":"329","author":"Martinez","year":"2023","journal-title":"JAMA"},{"key":"2026050720452096800_aaoag034-B159","doi-asserted-by":"publisher","first-page":"EVIDctcs2300291","DOI":"10.1056\/EVIDctcs2300291","article-title":"Lessons learned from National Heart, Lung, and Blood Institute Covid-19 clinical trials","volume":"3","author":"Thomas","year":"2024","journal-title":"NEJM Evid"},{"key":"2026050720452096800_aaoag034-B160","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1513\/AnnalsATS.202405-512IP","article-title":"Participation in clinical trials does not have to be a lousy experience","volume":"21","author":"Sculley","year":"2024","journal-title":"Ann Am Thorac Soc"},{"key":"2026050720452096800_aaoag034-B161","doi-asserted-by":"publisher","first-page":"e126","DOI":"10.1017\/cts.2024.568","article-title":"Returning individual research results to participants: values, preferences, and expectations","volume":"8","author":"Kent","year":"2024","journal-title":"J Clin Transl Sci"},{"key":"2026050720452096800_aaoag034-B162","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1093\/jamia\/ocab240","article-title":"Recruitment in a research study via chatbot versus telephone outreach: a randomized trial at a minority-serving institution","volume":"29","author":"Kim","year":"2021","journal-title":"J Am Med Inform Assoc"},{"key":"2026050720452096800_aaoag034-B163","doi-asserted-by":"publisher","first-page":"e2346598","DOI":"10.1001\/jamanetworkopen.2023.46598","article-title":"Global burden of chronic obstructive pulmonary disease through 2050","volume":"6","author":"Boers","year":"2023","journal-title":"JAMA Netw Open"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/advance-article-pdf\/doi\/10.1093\/annalsats\/aaoag034\/66852012\/aaoag034.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/23\/5\/667\/66852012\/aaoag034.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/23\/5\/667\/66852012\/aaoag034.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:45:31Z","timestamp":1778201131000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/23\/5\/667\/8472780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":163,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,2,11]]},"published-print":{"date-parts":[[2026,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/annalsats\/aaoag034","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,2,11]]}}}